This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Precision medicine is a promising new approach to the treatment of gastrointestinal (GI) disorders. It is an individualized approach to understanding and treating diseases by taking into account a person’s individual characteristics and environmental factors. This type of approach has the potential to revolutionize the way we treat and manage GI disorders. Precision medicine works by looking at a person’s unique genetic makeup, lifestyle, and environmental factors to develop a tailored treatment plan. This allows doctors to better understand the cause of a GI disorder and choose the most effective treatment option for that particular person. For example, precision medicine can be used to identify genetic mutations that are associated with a particular GI disorder, such as irritable bowel syndrome (IBS). This information can then be used to develop medications that are tailored to the individual’s specific needs. Precision medicine can also be used to monitor the effectiveness of treatment and to determine when changes need to be made. For example, the use of biomarkers can help to identify changes in the body that indicate a response to treatment. This information can then be used to adjust the treatment plan accordingly. Finally, precision medicine can be used to develop targeted therapies that are tailored to the individual’s specific needs. By looking at the individual’s specific genetic makeup and environmental factors, researchers can develop therapies that target the underlying cause of the GI disorder and potentially provide long-term relief. Overall, precision medicine offers a promising new approach to the treatment of GI disorders. By taking into account a person’s unique genetic makeup, lifestyle, and environmental factors, this individualized approach has the potential to revolutionize the way we treat and manage GI disorders.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States